XML 22 R12.htm IDEA: XBRL DOCUMENT

Intangible Assets

6 Months Ended

Dec. 31, 2023

Note 6 – Intangible Assets

Intangible assets, net consists of the following:


	December 31, 2023				Total		June 30, 2023				Total
	Finite Lived		Indefinite Lived		December 31,		Finite Lived		Indefinite Lived		June 30,
	Intangible Assets		Intangible Assets		2023		Intangible Assets		Intangible Assets		2023
Intangible Assets	$	153,393	$	305,561	$	458,954	$	153,393	$	305,561	$	458,954
Less Accumulated Amortization		(129,511)		—		(129,511)		(125,376)		—		(125,376)
Intangible Assets, Net	$	23,882	$	305,561	$	329,443	$	28,017	$	305,561	$	333,578

Amortization expense amounted to $2,068 and $2,068 for the three months ended December 31, 2023 and 2022, respectively, and for the six months ended December 31, 2023 and 2022 were $4,135 and $4,135, respectively.

NanoViricides, Inc.’s intangible assets include acquired licenses and capitalized patent costs representing legal fees associated with filing patent applications. Intangible assets with finite lives, licenses and patent costs, are amortized using the straight- line method over the estimated economic lives of the assets, which range from seventeen to twenty years. The Company’s intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable.

Intangible assets determined to have indefinite useful lives, primarily patent costs, are not amortized but are tested for impairment annually, or more frequently if events or changes in circumstances indicate the asset may be impaired. The Company accounts for patent costs in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) ASC 350-

30, General Intangibles Other than Goodwill. The Company will begin amortizing the patent costs when they are brought to the market or otherwise commercialized.

The Company does assess the recoverability of intangible assets with indefinite lives annually in the fourth quarter of each fiscal year, or more often if indicators warrant, by determining whether the fair value of each of the intangible assets, as a unit, supports its carrying value. In accordance with ASC 350, each year the Company may assess qualitative factors to determine whether it is more likely than not that the fair value of each license is less than its carrying amount as a basis for determining whether it is necessary to complete quantitative impairment assessments.